Chirfi Guindo - 03 Aug 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Chief Marketing Officer
Signature
/s/ Jon Filderman, as attorney-in-fact for Chirfi Guindo
Issuer symbol
MRK
Transactions as of
03 Aug 2023
Transactions value $
$1,998,998
Form type
4
Filing time
04 Aug 2023, 16:17:26 UTC
Previous filing
04 May 2023
Next filing
02 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $3.9M +36.9K +2561.36% $105.70 38.3K 03 Aug 2023 Direct F1
transaction MRK Common Stock Tax liability -$1.9M -18K -46.92% $105.70 20.4K 03 Aug 2023 Direct
holding MRK Common Stock-401(k) Plan 52.5 03 Aug 2023 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -36.9K -33.33% $0.00 73.8K 03 Aug 2023 Common Stock 36.9K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through July 10, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025.